IDEXX LABORATORIES INC /DE·4

Feb 3, 5:01 PM ET

HOOLEY JOSEPH L 4

Research Summary

AI-generated summary

Updated

IDEXX (IDXX) Director Joseph Hooley Receives 36 Deferred Shares

What Happened
Joseph L. Hooley, a director of IDEXX Laboratories (IDXX), was granted 36 deferred stock units on 2026-01-30 at an imputed price of $670.46 per unit, a total value of approximately $24,137. The Form 4 reports this as an award/acquisition (code A) under the IDEXX Director Deferred Compensation Plan.

Key Details

  • Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (appears timely under the two-business-day rule).
  • Grant: 36 deferred stock units at $670.46 per unit; aggregate reported value $24,137.
  • Footnote: Units were issued pursuant to the IDEXX Director Deferred Compensation Plan. The number of units was determined by dividing $24,375.00 of deferred cash compensation by the closing stock price and rounding to a whole unit (hence 36 units).
  • Vesting and payment: Units vest immediately but are payable only as common stock upon the director’s resignation from the board or on other nondiscretionary, objectively determinable dates per the Plan. Each unit represents a contingent right to one share.
  • Shares owned after the transaction: not specified in the filing.

Context
This was an award of deferred stock units (not an open-market purchase or sale). Such grants are routine compensation for directors and do not by themselves indicate a change in insider sentiment. The units convert to shares only under the Plan’s payout conditions and are intended as deferred compensation.